×
Evoke Pharma EBIT 2012-2024 | EVOK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Evoke Pharma ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Evoke Pharma EBIT 2012-2024 | EVOK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Evoke Pharma ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.9B
BridgeBio Pharma (BBIO)
$4.4B
Bausch Health Cos (BHC)
$2.9B
Amphastar Pharmaceuticals (AMPH)
$2.2B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$506M
Personalis (PSNL)
$245M
Assembly Biosciences (ASMB)
$96M
Sol-Gel Technologies (SLGL)
$15M
Teligent (TLGT)
$0M